Microsoft PowerPoint UTNP.ppt

Similar documents
Diagnosis of Dementia: Update

PET n = 7 AD n = 20 図 3 PiB AD A 3. わが国のアミロイド PET の現状 PET 100 PiB 15 BF 図 4 J-ADI 105 図 5 20%MCI 60% AD 90% MCI AD AD E ApoE 4 AD 4 図 6 4.

認知症治療薬の考え方,使い方

Vol.21 No AD Japanese-ADNI J-ADNI 2015 AMED AD NA-ADNI 400 AD AD 2. NA-ADNI 研究の主な成果 NA-ADNI 2004 NA-ADNI ADNI, ADNI-GO ADNI-2 phase

Ⅰ診断 症候 鑑別診断 認知機能に関する訴え 正常ではなく認知症でもない 認知機能の低下あり 日常生活機能は正常 Amnestic n-amnestic 認知障害は記憶障害のみ 認知障害は1領域に限られる Amnestic Single 図1 表1 記憶障害 Amnestic Multiple n

Dynamic Neuropathology of age- associated cognitive decline 村山繁雄 * 齊藤祐子 * 高齢者の認知障害は 個人においても集団においても連続的である これらの正確な解明には 臨床的縦断研究と 神経病理学的後方視的研究と組み合わせる以外ない


第61巻5・6号(12月号)/特集1頁目(本刷)


Microsoft Word - 01_2_【資料1】ICD最近の動向(脳卒中、認知症)170626(反映)

日本職業・災害医学会会誌第51巻第5号

臨床神経学雑誌第48巻第1号

untitled

dr igarashi

<95DB8C9288E397C389C88A E696E6462>

日本内科学会雑誌第97巻第7号

日本内科学会雑誌第98巻第4号

NL09

5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH mu/ml 0-5 /µl AST mu/ml CK mu/ml <25 mg/dl<45 mg/dl GLU

Microsoft Word - Dr. Haga.doc

[4], [5] [6] [7] [7], [8] [9] 70 [3] 85 40% [10] Snowdon 50 [5] Kemper [3] 2.2 [11], [12], [13] [14] [15] [16]

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Juntendo Medical Journal

untitled

スライド タイトルなし


信州大学?Curtin University of Technology 間学術交流協定にもとづく

2 94

J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN


Vol.0 No. 0 図 Montreal Cognitive AssessmentMoCA orientation visuospatial attention orientation 4 visuospatial executive MMSE MoCA language language me

PD_PET_Resume


DOUSHISYA-sports_R12339(高解像度).pdf

平成14年度 本態性多種化学物質過敏状態の調査研究 研究報告書

Core Ethics Vol.


ALDEFLUOR® 造血幹細胞/造血前駆細胞の新しい同定試薬

NL10

IPSJ SIG Technical Report Vol.2016-CE-137 No /12/ e β /α α β β / α A judgment method of difficulty of task for a learner using simple

) 5 Lawton QOL 4 4 QOL Lawton 4) Philadelphia Geriatric Center Affect Rating ScaleARS ARS QOL 5) HDS R

Microsoft Word - 21C04 神内2.docx



スライド 1

_PDF.indd

認知症診療ガイドライン2017_100_第1章.indd

早期教育の効果に関する調査(II)-親子の意識と学習状況の分析を中心に-


Unknown

Ł\”ƒ-2005

第90回日本感染症学会学術講演会抄録(I)

理学療法科学シリーズ臨床運動学第6版サンプル

Transcription:

Neuropathology Shigeo Murayama 2007.05.21 Department of Neuropathology (Brain Bank) Tokyo Metropolitan Institute of Gerontology Today s Themes A. General consideration Hierarchy of the nervous system Dynamic Neuropathology Clinical manifestation - Neurology & Psychiatry Neuroimages: CT, MRI, SPECT & PET Pathology: Mophology, Biochemistry & Molecular genetics B. Category of disorders 1. Cerebrovascular disorders -thrombosis, embolism, aneurysm, lacuna 2. Infectious disorders 3. Developmental, perinatal & metabolic disorders 4. Demyelinating disorders -multiple sclerosis 5. Neuromuscular disorders 6. Degenerative disorders, hereditary & sporadic -amyotrophic lateral sclerosis 7. Aging and dementing disorders - Alzheimer disease Parkinson disease Hierarchy of the Nervous System Cerebrum Basal ganglia Thalamus Cerebellum Brain Stem Spinal Cord Peripheral Nerve Muscle Localization Level Dynamic Neuropathology Neurology & Psychiatry Signs and symptoms - behavior Neurophysiology - EEG, EMG, NCV, EP Laboratory medicine: blood, urine and CSF Neuroradiology CT scan - X-ray based MRI - NMR SPECT - radioisotope PET - positron Correlation with Neuropathology Neuropathology Morphology Routine staining: - hematoxylin and eosin Special staining: Nissl - mrna - neuron luxol fast blue - lipid - myelin silver staining Bodian neurofilament - axon Gallyas-Braak tau - tangle Methenamine beta amyloid - plaque Bielshowsky Immunohistochemsitry Ultrastructural study Protein biochemistry Molecular biology Cellular Pathology Immunohistochemistry amyloid β plaque τ, phosphorylated tangle α-synuclein, phosphorylated Lewy body ubiquitin glial-fibrillary acidic protein: astrocytes MHC class II (HLA-DR): microglia Factor VIII endotheil Ultrastructural study organella, abnormal accumulation 1

Brain Bank Official system (infrastructure) to provide human brain tissue for neuroscience research 1. Dutch Brain Bank living will, official + private, providing tissue worldwide 2. U.S.A. 350 brain banks, NIH funded, connecting researcher A Gift of Hope movement 3. EC EC Brain Network 提供者証明書 ( 死亡の際は直ちに Brain-Net センターへ電話連絡を ) ドイツブレインネット ドイツブレインネット剖検施設ネットワーク 4. U.K. Brain Donation for Next Generation movement 5. Australia A Gift of Hope movement 6. Brain Bank for Aging Research funded by Tokyo Metropolitan Geriatric Hospital, Tokyo Metropolitan Institute of Gerontology and Japanese Ministries of Education, Culture, Sports, Science, and Technology & Health, Labor and Welfare ( 裏面 ) (Brain-Net センターアドレス ) ( 提供者氏名 ) ( 提供者署名 ) 赤 : 独立した神経病理施設黄 : 病理施設下の神経病理部門 Gross Anatomy 1. To identify representative structures 2. Most important for accurate diagnosis 3. Requiring careful clinical and pathological correlation Brain Cutting Session 2

3

4

5

脳血管障害 脳動脈硬化 脳底動脈血栓症 動脈硬化 生活習慣病生活習慣の改善で予防可能 6

7

CJD Protocol Sequence study of prion gene Immunoblot of frozen brain Immunohistochemistry with anti-prion antibody hippocampus, processed as below 1-3mM HCl 121 o C 10 minutes atuoclave 99% formic acid: 5 minutes Tissue processing fixed in formalin :>1week processed in 99% formic acid: 1hr post-fixed in formalin overnight embedded in paraffin Immunoblot with anti-prion antibody (3F4) 8

Multiple sclerosis Inflammtory demyelination involoving the central nervous system Multiple occurrence both in time and space Three clinical types: relapsing-remittent secondary progressive primary progressive Myelin Axon Myelin Axon Triplet repeat disease 1. Abnormal expansion of CAG repeats in the exons of the responsible gene, translating into polyglutamine 2. Accumulation of polyglutamine in the nucleus and cytoplasm 3. Selective neuronal degeneration Huntington disease: caudate nucleus SCA3/ MJD: pons, cerebellum spinal cord, basal ganglia DRPLA: dentate-rubllo-pallido-luysain atrophy Huntington Control 9

Amyotrophic lateral sclerosis 1. Progressive weakness and atrophy 2. Death due to respiratory failure 3. Intact intellectual function 4. A subgroup of familial case caused by mutation of superoxide dismutase 1 (SOD1), leading to the accumulation of ubiquitinated abnormal SOD1 Intraneuronal inclusion 10

Aging and Dementia Abnormal accumulation of posttranslated proteins β amyloid = Alzheimer disease (senile plaques) accompanying secondary tauopathy (tangles) hereditary - mutation in APP, PS1 & 2 sporadic - association with apoe4 τ = tauopathy hereditary - FTDP17- mutation in τ gene sporadic - Pick s disease α-synuclein = synucleinopathy - Parkinson s disease hereditary - α-synuclein gene, mutation, dupulicaion Parkin gene (ubiquitin ligase), LRRK2 sporadic - Lewy body disease multiple system atrophy Alzheimer s disease The most common cause of dementia Progressive cognitive decline Amyloid cascading hypothesis accumulation of β amyloid (Aβ) abnormal phosphorylation of τ protein β & γ secretase cleaves amyloid precursor protein (APP) to form Aβ Vaccination of Aβ halted by complication of fatal encephalitis Acetylcholine esterase inhibitor, transiently effective AD 70Y Averaged FDG-PET Images in Alzheimer s Disease 83Y Normal N=12 Mild AD HDRS>20 N=6 Moderate AD HDRS 10~20 N=7 Severe AD HDRS<10 N=6 11

軽度認知機能障害 : 初期アルツハイマー病疑 Comparison with 21 normals ANCOVA p<0.01 MCI 76 M Alzheimer disease Control 12

Immunization with Aβ 容量計測 MRI(voxel based morphometry) 70 代女性 物忘れ MMSE28 点 Experimental evidence with clearance of Aβ Phase I trial, uneventful Phase II study, suspended due to fatal encephalitis Clearance of Aβ, confirmed at autopsy 海馬に萎縮があるのかどうか 視診上 断定できない 80 代女性 認知症 MMSE18 点 VSRAD 統計解析では 海馬傍回萎縮は青で示される アルツハイマー病初期の可能性を含めてフォローを要する Z score1.9 軽度萎縮は疑えるが 判断に困難を感ずるのは間違いない Z score 2.2 髄液バイオマーカー τ Pτ Aβ HVA 5HIAA アルツハイマー病 MRI 糖代謝ペット (FDG) アミロイドベータ蛋白 (PIB) ペット所見 パーキンソン病 レヴィー小体型痴呆 進行性核上性麻痺 神経原線維変化 優位型痴呆 嗜銀顆粒性痴呆 皮質基底核変性症 クロイツフェルト ヤコブ病 ブレインバンク生前同意登録者 ( アルツハイマー病疑い ) 13

Pick s disease Six Isoforms of τ protein Prototypes of frontotemporal dementia Famous but infrequent (about 1% of Alzheimer s disease) Pure tauopathy Lobar atrophy Pick body FTDP17 66M Pick/ Pick 68 14

Parkinson s disease The most common degenerative disease, causing motor and cognitive impairment in the elderly Treatable disease with L-Dopa Accumulation of phosphorylated α-synuclein, forming Lewy body and Lewy neurites Active role of α-synuclein, confirmed by familial Parkinson disease with mutation, or triplication Close association with ubiquitin Systemic disease involving both central and peripheral nervous system 15

Ser129 phosphorylated α-synuclein Specific monoclonal antibody (#64) 129 1 P 140 A30P A53T LB509 124 129 134 AYEMPSEEGYQ PO 3 H 2 Multiple system atrophy 1. Sporadic neuroglial synucleinopathy 2. Most common cause of spinocerebellar degeneration 3. Three systems, involved Olivo-ponto-cerebellar system Striato-nigral system Autonomic system 16

17